Immunological aspects of cancer chemotherapy

Cited by (1,000)

Items 701–800 of 1,000

1. Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapy
   Takaaki Tsuchiya, Masanori Someya, Yu Takada, Tomokazu Hasegawa, Mio Kitagawa, Yuki Fukushima, Toshio Gocho, Masakazu Hori, Kensei Nakata, Yoshihiko Hirohashi et al. · 2020 · Strahlentherapie und Onkologie
2. Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
   Erwan Eriau, Juliette Paillet, Guido Kroemer, Jonathan G. Pol · 2021 · Cancers
3. Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
   Cheng Frank Zhong, Yirun Li, Jing Yang, Shengxi Jin, Guoqiao Chen, Duguang Li, Xiaoxiao Fan, Hui Min Lin · 2021 · Frontiers in Oncology
4. Monoclonal Antibody Therapies for High Risk Neuroblastoma
   Wayne Lee Furman · 2021 · Biologics
5. Alternol triggers immunogenic cell death via reactive oxygen species generation
   Changlin Li, Ying Zhang, Siyuan Yan, Guoan Zhang, Wei Wei, Zhi Qi, Benyi Li · 2021 · OncoImmunology
6. Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model
   Seiichiro Inoue, Yumiko Setoyama, Akio Odaka · 2014 · Experimental and Therapeutic Medicine
7. Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
   Sara Cecco, Elena Muraro, E. Giacomin, Debora Martorelli, Renzo Lazzarini, Paolo Baldo, Riccardo Dolcetti · 2010 · Current Cancer Drug Targets
8. Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
   Mickaël Michaud, Abdul Qader Sukkurwala, Federica Di Sano, Laurence Zitvogel, Oliver Kepp, Guido Kroemer · 2014 · OncoImmunology
9. Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin
   Chi‐Ping Day, John Carter, Carrie Bonomi, Melinda G. Hollingshead, Glenn T Merlino · 2011 · International Journal of Cancer
10. Translational research on advanced therapies.
    Filippo Belardelli, Paola Rizza, Franca Moretti, Cintia Carella, María Cristina Galli, Giovanni Migliaccio · 2011 · PubMed
11. The potential of immunomodulators in shaping the future of healthcare
    Yash Sharma, Muskan Arora, Kumud Bala · 2024 · Discover Medicine
12. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
    Connie Jackaman, Delia Jane Nelson · 2013 · Experimental Gerontology
13. Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial
    Robert Scott Svatek, Xiang R. Zhao, Edwin E. Morales, Mithilesh K. Jha, Timothy Y. Tseng, Cory Michael Hugen, Vincent J. Hurez, Javier Hernández, Tyler Jay Curiel · 2014 · Clinical Cancer Research
14. Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival
    Mariana Brutschin Pereira, Luciana Rodrigues Carvalho Barros, Paula Andreghetto Bracco, Álvaro Vigo, Mariana Boroni, Martín Bonamino, Guido Lenz · 2018 · OncoImmunology
15. Effect of lactoferrin on taste and smell abnormalities induced by chemotherapy: a proteome analysis
    Aili Wang, Susan Ellen Duncan, Glenn Jay Lesser, William Keith Ray, Andrea M. Dietrich · 2018 · Food & Function
16. The 100 top-cited studies in cancer immunotherapy
    Yonggang Zhang, Liuliu Quan, Liang Du · 2019 · Artificial Cells Nanomedicine and Biotechnology
17. Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial
    Masanori Noguchi, Gaku Arai, Shin Egawa, Chikara Οhyama, Seiji Naito, Kazumasa Matsumoto, Hirotsugu Uemura, Masayuki Nakagawa, Yasutomo Nasu, Masatoshi Eto et al. · 2020 · Cancer Immunology Immunotherapy
18. Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies
    Silverio Ros, Diana Navas-Carrillo, José Luis Alonso-Romero, Esteban Orenes‐Piñero · 2020 · Critical Reviews in Clinical Laboratory Sciences
19. Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
    Benson Chellakkan Selvanesan, Kiran Meena, Amanda P. Beck, Lydie Meheus, Olaya Lara, Ilse Rooman, Claudia Gravekamp · 2020 · Journal for ImmunoTherapy of Cancer
20. Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy
    Xing Chen, Xiang Ling, Jiaxuan Xia, Ying Zhu, Longlong Zhang, Yuwei He, Anni Wang, Guolong Gu, Bo Yin, Jianxin Wang · 2021 · Bioactive Materials
21. Insights on the Dynamic Innovative Tumor Targeted-Nanoparticles-Based Drug Delivery Systems Activation Techniques
    Nadia Μ. Hamdy, Georgette Eskander, Emad B. Basalious · 2022 · International Journal of Nanomedicine
22. Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells
    Xiang Huang · 2011 · World Journal of Gastroenterology
23. Novel aspects of preoperative chemoradiation therapy improving anti‐tumor immunity in pancreatic cancer
    Takahiro Tsuchikawa, Satoshi Hirano, Eiichi Tanaka, Joe Matsumoto, Kentaro Kato, Toru Nakamura, Yuma Ebihara, Toshiaki Shichinohe · 2013 · Cancer Science
24. Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity
    Cristina Garrido, Ignacio Algarra, Isabel Maleno, Julia Stefanski, Antonia Collado, Federico Garrido, Angel Miguel Garcia-Lora · 2009 · Cancer Immunology Immunotherapy
25. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage
    Liang‐Ru Ke, Yan‐Qun Xiang, Wei‐Xiong Xia, Jing Yang, Ya‐Hui Yu, Yan‐Fang Ye, Liang Hu, Xiang Guo, Xing Lv · 2016 · Clinical Immunology
26. Predictive Biomarkers in the Treatment of Her2-Positive Breast Cancer: An Ongoing Challenge
    Tiziana Triulzi, Giulia Bianchi, Elda Tagliabue · 2016 · Future Oncology
27. Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents
    Iva Truxová, Michal Hensler, Petr Škapa, Michael J. Halaška, Ján Laco, Aleš Ryška, R. Spisek, J. Fucikova · 2016 · International review of cytology
28. Cyclophosphamide enhances anti-tumor effects of a fibroblast activation protein α-based DNA vaccine in tumor-bearing mice with murine breast carcinoma
    Xia Qiu, Fei Geng, Fang-Fang Zhang, Chenlu Liu, Ping Xu, Zhen-Zhen Lu, Yu Xie, Bo Sun, Hui Wu, Bin Yu et al. · 2016 · Immunopharmacology and Immunotoxicology
29. Systemic Therapy for Unresectable Metastatic Melanoma: Impact of Biochemotherapy on Long-Term Survival
    Agop Y. Bedikian, Marcella M. Johnson, Carla L. Warneke, Susan E McIntyre, Nicholas Papadopoulos, Wen‐Jen Hwu, Kevin Kim, Patrick Hwu · 2008 · Journal of Immunotoxicology
30. Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays
    Ilya Yakavets, Sina Kheiri, Jennifer Cruickshank, Riley J. Hickman, Faeze Rakhshani, Matteo Aldeghi, Ella Miray Rajaonson, Edmond W. K. Young, Alán Aspuru‐Guzik, David W. Cescon et al. · 2025 · Science Advances
31. Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms
    Filippo Bellati, Chiara Napoletano, Maria Luisa Gasparri, Ilary Ruscito, Cláudia Marchetti, Sandro Pignata, Federica Tomao, Pierluigi Benedetti Panici, Marianna Nuti · 2011 · Critical Reviews in Oncology/Hematology
32. Integration of Host-Related Signatures with Cancer Cell–Derived Predictors for the Optimal Management of Anticancer Chemotherapy
    Laurence Zitvogel, Oliver Kepp, Laetitia Aymeric, Yuting Ma, Clara Locher, Nicolas F. Delahaye, Fabrice André, Guido Kroemer · 2010 · Cancer Research
33. Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation.
    Dai Otsubo, Kimihiro Yamashita, Mitsugu Fujita, Masayasu Nishi, Yutaka Kimura, Hiroshi Hasegawa, Satoshi Suzuki, Yoshihiro Kakeji · 2015 · PubMed
34. High-density lipoprotein modulates tumor-associated macrophage for chemoimmunotherapy of hepatocellular carcinoma
    Junyang Wang, Chao Zheng, Yihui Zhai, Ying Cai, Robert J. Lee, Jianming Xing, Hao Wang, Helen He Zhu, Lesheng Teng, Yaping Li et al. · 2021 · Nano Today
35. Thermal-responsive magnetic hydrogels based on Tragacanth gum for delivery of anticancer drugs
    Sahar Sayadnia, Elham Arkan, Rana Jahanban‐Esfahlan, Soughand Sayadnia, Mehdi Jaymand · 2021 · Journal of Polymer Research
36. The Peripheral Immune Landscape of Breast Cancer: Clinical Findings and In Vitro Models for Biomarker Discovery
    Sofia Batalha, Sofia Cristóvão‐Ferreira, Catarina Brito · 2021 · Cancers
37. Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
    Gilberto Filaci, Daniela Fenoglio, Franco Nolè, Elisa Zanardi, Laura Tomasello, Massimo Aglietta, Gianluca Del Conte, Joan Carles, Rafael Morales‐Barrera, Pamela Guglielmini et al. · 2021 · Cancer Immunology Immunotherapy
38. Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity
    Nadia de Gruil, Hanno Pijl, Sjoerd H. van der Burg, Judith R. Kroep · 2022 · Cancers
39. IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
    Connie Jackaman, Danielle E. Dye, Delia Jane Nelson · 2014 · AGE
40. KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
    David T. O. Yeung, Carine Tang, Ljiljana Vidovic, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S. M. Yong · 2015 · Blood
41. Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals
    Frank Madeo, Michael Durchschlag, Oliver Kepp, Theocharis Panaretakis, Laurence Zitvogel, Kai‐Uwe Fröhlich, Guido Kroemer · 2009 · Cell Cycle
42. AIEgens for synergistic anticancer therapy
    Xinyan Lyu, Junjie Yu, Liping Zhang, Yun Zhao, Zijie Qiu, Youbai Chen, Zheng Zhao, Ben Zhong Tang · 2023 · Journal of Materials Chemistry B
43. Synthetic Mesh Versus Acellular Dermal Matrix for Oncologic Chest Wall Reconstruction: A Comparative Analysis
    Salvatore A. Giordano, Patrick Bryan Garvey, Mark Warren Clemens, Donald Peter Baumann, Jesse Creed Selber, David C. Rice, Charles E. Butler · 2020 · Annals of Surgical Oncology
44. Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy
    Ying Zhang, Ramar Thangam, Sung-Hwan You, Rukhsora D. Sultonova, Akhil Venu, Jung‐Joon Min, Yeongjin Hong · 2021 · Cancers
45. MYC Ran Up the Clock: The Complex Interplay between MYC and the Molecular Circadian Clock in Cancer
    Jamison B. Burchett, Amelia M. Knudsen-Clark, Brian James Altman · 2021 · International Journal of Molecular Sciences
46. Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma
    Natalia Di Ianni, Martina Maffezzini, Marica Eoli, Serena Pellegatta · 2021 · Frontiers in Oncology
47. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
    Tarek M. A. Abdel-Fatah, Stéphanie McArdle, Catherine Johnson, Paul M. Moseley, Graham Ball, Alan Graham Pockley, Ian Ogilvie Ellis, Robert C. Rees, Stephen Y.T. Chan · 2014 · British Journal of Cancer
48. T-cell immunotherapy for malignant glioma: toward a combined approach
    Pierre‐Yves Dietrich, Valérie Dutoit, Nhu Nam Tran Thang, Paul R. Walker · 2010 · Current Opinion in Oncology
49. Serum biomarkers of cell death for monitoring therapy response of gastrointestinal carcinomas
    Doreen Brandt, Xandra Volkmann, Matthias Anstätt, Florian Peter Länger, Michael Peter Manns, Klaus Schulze‐Osthoff, Heike Bantel · 2010 · European Journal of Cancer
50. Tyrosine kinase inhibitors in the treatment of prostate cancer: taking the next step in clinical development
    Michelle A. Ojemuyiwa, Ravi Amrit Madan, William L. Dahut · 2014 · Expert Opinion on Emerging Drugs
51. Genome-wide identification of long non-coding RNA and mRNA profiling using RNA sequencing in subjects with sensitive skin
    Li Chun Yang, Lechun Lyu, Wenjuan Wu, Dongyun Lei, Ying Tu, Dan Xu, Jiaqi Feng, Li He · 2017 · Oncotarget
52. Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen
    Siqi Guo, Jun Xu, Warren L. Denning, Zdeněk Hel · 2009 · Gene Therapy
53. Immunotherapeutics for breast cancer
    Carmen Criscitiello, Giuseppe Curigliano · 2013 · Current Opinion in Oncology
54. Carboplatin and programmed death‐ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID 8 ovarian cancer model
    Xinxin Zhu, Jia Meng Xu, Han Cai, Jinghe Lang · 2017 · Journal of obstetrics and gynaecology research
55. Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer
    Debra Wu, Zongmin Zhao, Jayoung Kim, Amaya Najma Razmi, Liwen Wang, Neha Kapate, Yongsheng Gao, Kevin Peng, Anvay Ukidve, Samir Mitragotri · 2020 · Bioengineering & Translational Medicine
56. Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice
    Marcus Schmidt, Anne-Sophie Heimes · 2021 · Cancers
57. Multi‐shelled Dendritic Mesoporous Organosilica Hollow Spheres: Roles of Composition and Architecture in Cancer Immunotherapy
    Yannan Yang, Yao Lu, Prasanna Lakshmi Abbaraju, Jun Zhang, Min Zhang, Guangya Xiang, Chengzhong Yu · 2017 · Angewandte Chemie
58. Role of myeloid-derived suppressor cells in tumor recurrence
    Kathryn Cole, Zaid S Al-Kadhimi, James E. Talmadge · 2023 · Cancer and Metastasis Reviews
59. Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy
    Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Ko Sato, Satoshi Shoji, Natsue Igarashi, Rie Kondo, Masaaki Okajima, Jun Koshio et al. · 2015 · The Journal of Immunology
60. Tumour infiltrating host cells and their significance for hyperthermia
    Munitta Muthana, Gabriele Multhoff, Alan Graham Pockley · 2010 · International Journal of Hyperthermia
61. Immunotherapy in the landscape of new targeted treatments for non‐small cell lung cancer
    Catherine M. Gerard, C. Debruyne · 2009 · Molecular Oncology
62. Oral Administration of Immunopotentiator from Pantoea agglomerans 1 (IP-PA1) Improves the Survival of B16 Melanoma-Inoculated Model Mice
    Takehisa Hebishima, Yasunobu Matsumoto, Gen Watanabe, Gen‐Ichiro Soma, Chie Kohchi, Kazuyoshi Taya, Yoshihiro Hayashi, Yoshikazu Hirota · 2011 · EXPERIMENTAL ANIMALS
63. Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer
    Nadine Tung, Eric P. Winer · 2015 · Journal of Clinical Oncology
64. Application of stimuli responsive nanocomposites in drug delivery and theranostics to counter cancer proliferation and drug resistance
    Namrata Khanna, Tanushri Chatterji, Suruchi Singh, Sadanand Pandey · 2023 · Journal of Drug Delivery Science and Technology
65. The Structure–Antiproliferative Activity Relationship of Pyridine Derivatives
    Ana-Laura Villa-Reyna, Martín Pérez-Velázquez, Mayra L. González‐Félix, J.C. Galvez-Ruiz, Dulce María González Mosquera, Dora Valencia, Manuel G. Ballesteros‐Monrreal, Milagros R. Aguilar-Martínez, Mario Alberto Leyva‐Peralta · 2024 · International Journal of Molecular Sciences
66. IL-7 signaling imparts polyfunctionality and stemness potential to CD4+ T cells
    Zhi‐Chun Ding, Chufeng Liu, Yang Cao, Tsadik Ghebreamlak Habtetsion, Michal Kuczma, Wenhu Pi, Heng Kong, Ercan Çaçan, Susanna Fletcher Greer, Yan Ru Cui et al. · 2016 · OncoImmunology
67. Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy
    Reza Alimohammadi, Razie Alibeigi, Amin Reza Nikpoor, Ghanbar Mahmoodi Chalbatani, Thomas Jay Webster, Mahmoud Reza Jaafari, Seyed Amir Jalali · 2020 · International Journal of Nanomedicine
68. Nanotechnology-based multifunctional vaccines for cancer immunotherapy
    Xiaoxue Xie, Ting Song, Yi Feng, Hanxi Zhang, Geng Yang, Chunhui Wu, Fengming You, Yiyao Liu, Hong Yang · 2022 · Chemical Engineering Journal
69. Nanotoxoid vaccination protects against opportunistic bacterial infections arising from immunodeficiency
    Jiarong Zhou, Nishta Krishnan, Zhongyuan Guo, Christian J. Ventura, Maya Holay, Qiangzhe Zhang, Xiaoli Wei, Weiwei Gao, Ronnie H. Fang, Liangfang Zhang · 2022 · Science Advances
70. Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer
    Max Heiduk, Ioana Plesca, Jessica Glück, Luise Müller, David Digomann, Charlotte Reiche, Janusz von Renesse, Rahel Decker, Christoph Kahlert, Ulrich J. Sommer et al. · 2022 · JCI Insight
71. Cancer immunotherapy: Progress and challenges in the clinical setting
    Hassane M. Zarour, Soldano Ferrone · 2011 · European Journal of Immunology
72. Tumor-infiltrating lymphocytes in breast cancer
    Yasmin Issa-Nummer, Sibylle Loibl, Gϋnter von Minckwitz, Carsten Denkert · 2014 · OncoImmunology
73. Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
    Naomi L. Dunning, Stéphanie A. Laversin, Amanda Kathleen Miles, Robert C. Rees · 2011 · Cancer Immunology Immunotherapy
74. Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation
    Apostolis Stathopoulos, Chrystel M. Pretto, Laurent Devillers, P. Denis, Florence M. Hofman, Carol A. Kruse, Martin R. Jadus, Thomas C. Chen, Virgil E. C. J. Schijns · 2012 · OncoImmunology
75. A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy
    Mark Robertson‐Tessi, Ardith W. El-Kareh, Alain Goriely · 2015 · Journal of Theoretical Biology
76. Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model
    Gnanaprakasam, J.N. Rashida, López-Bañuelos, Laura, Vega, Libia · 2021 · Toxicology and Applied Pharmacology
77. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer
    Qi He, Guoli Li, Xiang Ji, Long Ma, Xulin Wang, Yang Li, Chaogang Fan · 2017 · Tumor Biology
78. Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!
    Melanie Grant, Catherine M. Bollard · 2017 · Blood Reviews
79. The immunomodulatory effects of Carapax Trionycis ultrafine powder on cyclophosphamide‐induced immunosuppression in Balb/c mice
    Xuhui Chen, Shasha Wang, Guangjing Chen, Zhirong Wang, Jianquan Kan · 2020 · Journal of the Science of Food and Agriculture
80. Integrating Immunotherapy with Chemotherapy: A New Approach to Drug Repurposing
    Hina Qayoom, Umar Mehraj, Shariqa Aisha, Shazia Sofi, Manzoor Ahmad Mir · 2021 · IntechOpen eBooks
81. Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer
    Ann Taber, Frederik Prip, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Torben Steiniche, Lars Dyrskjøt · 2022 · European Urology Oncology
82. Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
    Jihong Bae, Kwangcheon Park, You‐Me Kim · 2022 · Immune Network
83. Promotion of anti-keyhole limpet hemocyanin IgM and IgG antibody productions in vitro by red bell pepper extract
    Md. Moklesur Rahman Sarker, Eiichi Gohda · 2013 · Journal of Functional Foods
84. Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches
    Ann P. Chidgey, Natalie Seach, Jarrod A. Dudakov, Maree V. Hammett, Richard L. Boyd · 2008 · Seminars in Immunopathology
85. In vivo imaging of therapy-induced anti-cancer immune responses in humans
    Erik H.J.G. Aarntzen, Mangala Srinivas, Caius G. Radu, Cornelis J.A. Punt, Otto C. Boerman, Carl Gustav Figdor, Wim J.G. Oyen, I. Jolanda M. de Vries · 2012 · Cellular and Molecular Life Sciences
86. Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy
    Frederick Arce Vargas, Grazyna T. Kochan, Karine Breckpot, Holly N. Stephenson, David Escors · 2012 · Anti-Cancer Agents in Medicinal Chemistry
87. Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer
    Xinjun Cai, Zeng Wang, Jiawei Cao, Jian-Jun Ni, Yingying Xu, Jun Yao, Hong Xu, Fang Liu, Gaoyi Yang · 2017 · Oncotarget
88. Adenosine, bridging chronic inflammation and tumor growth
    Luxia Chen, Mohamad Alabdullah, Karsten Mahnke · 2023 · Frontiers in Immunology
89. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy
    Oliver J. Stoetzer, Christin Wittwer, Julia Lehner, Yvonne Nadine Fahmueller, Nikolaus Kohles, Debora M.I. Fersching, Gloria Sarah Leszinski, Juliane Roessner, Stefan Holdenrieder · 2012 · Expert Opinion on Biological Therapy
90. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer
    Elisa Elena Baracco, Federico Pietrocola, Aitziber Buqué, Norma Bloy, Laura Senovilla, Laurence Zitvogel, Erika Vacchelli, Guido Kroemer · 2016 · OncoImmunology
91. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth
    María del Carmen Rodríguez‐Salazar, Moisés Ármides Franco-Molina, Edgar Mendoza-Gamboa, Ana Carolina Martínez‐Torres, Pablo Zapata‐Benavides, José Sullivan López-González, Erika Evangelina Coronado-Cerda, Juan Manuel Alcocer-González, Reyes S. Taméz-Guerra, Cristina Rodríguez-Padilla · 2017 · Oncology Letters
92. [Retracted] Structural, Optical, Antibacterial, and Anticancer Properties of Cerium Oxide Nanoparticles Prepared by Green Synthesis Using Morinda citrifolia Leaves Extract
    Abozer Y. Elderdery, Badr Alzahrani, Abdulrahim A. Alabdulsalam, Siddiqa M. A. Hamza, Ahmed M. E. Elkhalifa, Abdulaziz H. Alhamidi, Fehaid Ghali Alanazi, Ahmed Mohamedain, Suresh S. Kumar, Pooi Ling Mok · 2022 · Bioinorganic Chemistry and Applications · Retracted
93. Cancer organoid applications to investigate chemotherapy resistance
    Kenji Harada, Naoya Sakamoto · 2022 · Frontiers in Molecular Biosciences
94. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy
    Guojun Huang, Lanlan Liu, Hong Pan, Lintao Cai · 2022 · Small Methods
95. Circulating apoptotic markers in the management of non-small cell lung cancer
    Stefan Holdenrieder, P Stieber · 2010 · Cancer Biomarkers
96. Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity
    Feng‐Qiang Yang, Yang Washington Shao, Fengping Yang, Ming Liu, Jianhua Huang, Kai Zhu, Chuanyong Guo, Jun Luo, Wei Li, Bin Yang et al. · 2013 · Archives of Medical Science
97. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines
    Katherine G. Sanchez, David B. Page, Heather L. McArthur · 2016 · Current Problems in Cancer
98. A systems biology approach to overcome TRAIL resistance in cancer treatment
    Kumar Selvarajoo · 2017 · Progress in Biophysics and Molecular Biology
99. Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis
    Xuerui Zhang, Lina Huo, Haibo Jin, Yuheng Han, Jie Wang, Yanjun Zhang, Xing-huan Lai, Ziwei Le, Jing Zhang, Zichun Hua · 2017 · Oncotarget
100. GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up
     Michele Caraglia, Pierpaolo Correale, Rocco Giannicola, Nicoletta Staropoli, Cirino Botta, Pierpaolo Pastina, Antonello Nesci, Nadia Caporlingua, Edoardo Francini, Laura Ridolfi et al. · 2019 · Frontiers in Oncology